In an attempt to find the extent to which Clostridium difficile could be implicated as the cause of antibiotic-associated diarrhoea, the stools of 53 patients who had diarrhoea after a course of antibiotics were investigated for the presence of C. difficile toxin. Ten of the patients (19 %) were found to be positive, but the stools of four out of 53 patients without diarrhoea after a course of antibiotics were also found to contain C. difficile toxin (7.5 %0). The titre of toxin in patients both with and without diarrhoea fell within the same range (up to 10-5). Neither the organism nor its toxin was found in the stool of 26 patients with ulcerative colitis, eight with Crohn's disease, 49 with non-specific diarrhoea, and 27 normal controls. We conclude that, while C. difficile is responsible for a proportion of cases of antibiotic-associated diarrhoea, the concentration of toxin is not the sole factor affecting the severity of this disorder.
Pseudomembranous colitis has been reported sporadically for over a century, but it is only since the advent of the antibiotic era that the condition has become relatively common. It had been suggested that the disorder was due to alteration of the colonic flora, but, for many years, no pathogenic organism common to all cases of pseudomembranous colitis could be isolated. However, in recent years it has been shown that Clostridium difficile is the causative organism,1-5 damage being associated with a cytopathic endotoxin which can be neutralised in vitro by the antitoxin to C. sordellii.
While pseudomembranous colitis is still a relatively rare disorder, diarrhoea occurring after a course of antibiotics is quite a frequent occurrence6-7 and it was therefore felt that such patients should be investigated to ascertain whether C. difficile could also be implicated in these cases.
Methods

PATIENTS
Stool samples were collected from 53 patients with diarrhoea during or immediately after a course of antibiotics (Table 1) . The patients' symptoms ranged from a mild short-lived episode of diarrhoea of four or more liquid stools per day to severe bloody diarrhoea with systemic illness. The range of anti- 
Techniques
The faecal filtrates were prepared by suspending the stool in normal saline at a dilution of 1 in 2 for 34 liquid stools and 1 in 3 or 1 in 4 for the more solid stools. The suspensions were centrifuged at 10 000 g for 30 minutes at 4°C and passed through 0.22 filters. The filtrates were stored at -400C. Toxin assay was performed on confluent monolayers of HeLa cells, 0.1 ml of each filtrate being added to 1 ml of culture medium. C. difficile toxin was considered to be present when a typical cytopathic effect was seen after 24 or 48 hours and could be neutralised by previous incubation with C.
sordelli antitoxin. The concentration of toxin was estimated by serial 10-fold dilutions in saline.
Culture of the stool sample was performed under strict anaerobic conditions, initially using modified cycloserine-celoxitin-fructose-egg yolk-agar (CCFA), as described by George et al.,' but latterly using a medium developed in our own laboratories (Columbia agar (oxoid) 40 g/l, egg yolk 5 %, Cycloserine 500 ,g/ml, cefoxin 16 pg/ml), which we found easier to prepare and use routinely.
Results
Of the 53 patients who had diarrhoea after a course of antibiotics, there were 10 patients whose stool contained C. difficile toxin. In all but one, the organism was also isolated, the exception being an early case occurring before a reliable method of culture had been perfected. One of the 10 patients had histologically proven pseudomembranous colitis, while two had severe colitis without pseudomembrane but with blood and pus in the stool and a systemic illness. Of the remainder, two were not submitted to sigmoidoscopy but the remaining five patients showed evidence of slight inflammation only, with loss of vascular pattern or erythema, although the diarrhoea in three cases was sufficiently severe to be the cause of their admission. The antibiotics administered and the reasons for their administration are shown in Table 2 ; it can be seen that, in most cases, the original diagnosis was a fairly trivial problem arising in a previously fit patient.
Neither the organism nor its toxin was isolated from any of the patients with Crohn's disease or ulcerative colitis, even in two whose exacerbation was related to a recent course of antibiotics, and those with non-specific diarrhoea and the normal controls were similarly negative.
However, of those who had received a course of at least seven days' antibiotics without developing diarrhoea, there were four patients whose stool contained C. difficile toxin, although the organism was not isolated from'two early cases who were seen before we were able to culture C. difficile reliably. None of these patients developed diarrhoea during the remainder of their hospital admission (two to three weeks). Antibiotics given and reasons for administration are shown in Table 3 .
The concentration of toxin in those patients with diarrhoea ranged from 10-2 to 10-s ( Table 2 ). The concentration in those patients without diarrhoea was either 10-4 or 10-a, in the same range as those with severe colitis (Table 3) . Other workers have studied the incidence of C. difficile in antibiotic-associated diarrhoea and other non-antibiotic-related gastrointestinal disorders. Bartlett et al."5 found that nine out of 63 patients with antibiotic-associated colitis without pseudomembrane had C. difficile toxin in their faeces, an incidence of 15 %, but they failed to isolate either organism or toxin from patients without diarrhoea after a course of antibiotics, although only 14 patients were studied. LaMont and Trnkal6 and Bolton et al.'7 have found several cases of inflammatory bowel disease in whom an exacerbation of symptoms has been associated with the identification of C. difficile toxin in the faeces. Improvement of the symptoms and eradication of toxin occurred after a course of vancomycin or metronidazole. We were unable to implicate C. difficile in exacerbations of inflammatory bowel disease, even in two patients with ulcerative colitis whose exacerbation appeared to be related to a course of antibiotics.
There do not appear to have been any previous reports of patients without diarrhoea after a course of antibiotics but with C. difficile toxin in the faeces. Bartlett et al.'8 have found that the concentration of toxin in the faecal filtrates has correlated in most cases with the severity of the disease, those for antibiotic associated diarrhoea having a mean of 10-2 and those for colitis a mean of 10-3 with a maximum of 10-7. However, although in two cases (patients 3 and 6, Table 2 ) stool samples were not available when symptoms were maximal, the severity of symptoms in the patients studied did not appear to correlate with the concentration of faecal toxin; indeed, in those who failed to develop diarrhoea, the concentration was well within the range found in those patients with severe symptoms. Thus other factors appear to be involved in the pathogenesis of the disorder than the mere presence of a certain concentration of toxin in the colon. Healthy infants seem able to tolerate the presence of C. difficile toxin without any ill effects" 14 and C. difficile associated colitis is only rarely reported in children only one of our cases being under the age of 16 years. The reason for this apparent tolerance is not clear; it appears that the infant colon is in some way resistant to the effects of the toxin and it may be that some adults are able to retain this resistance, or acquire some form of immunity, either local or systemic after exposure in infancy. Bartlett18 was unable to find any evidence of antitoxin production in the convalescent serum of patients with pseudomembranous colitis, but we have found toxin neutralising activity in the serum of one patient with a one month history of antibiotic-associated diarrhoea;19 whether such neutralising activity has a protective role has yet to be ascertained.
In conclusion, it would seem that Clostridium difficile is responsible for a proportion of cases of antibiotic-associated diarrhoea with a wide spectrum of response, ranging from no symptoms to pseudomembranous colitis, but that the presence of C. difficile toxin in the colon is not the sole factor affecting the severity of the disease.
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